dropped within 24 hours at the request of the bondholders, but would reappear later, following the eventual sale of Team Internet. In August 2019 the offer for Team Internet was dropped, but in the same month, Matomy reported that it had received multiple non-binding offers for Team Internet that would likely enable it to meet all its financial obligations. Sale of Team Internet Team Internet was sold in December 2019 to CentralNic for $48M, comprising $45M of cash and $3M in shares. The first payment of $44M, together with $3M of Matomy's cash, was used to purchase the final 10% of Team Internet from Rainmaker and to repay the bondholders in full. Matomy is due to receive a second payment six months after the acquisition of $1.8M, and a third payment of $600K fifteen months after the acquisition. Matomy also received 3,911,650 shares in CentralNic, subject to a lock-up period of 12–18 months. Matomy also received interest whilst the deal was being finalised, of approximately $800K. This transaction left Matomy with no active business. Offer for the cash shell On the day preceding the sale of Team Internet, director Nir Tarlovsky sold his stake in Matomy, followed the day after by ex-director Ilan Shiloah. On the same day a hostile takeover was announced by Kfir Silberman. He sent a letter to the company declaring that he had taken a 5% stake in the company and requested that no action be taken in the company's assets until the directors of Medigus, an Israeli Medical device maker that Silberman controlled, had been made directors of Matomy. Separately, Globes reported that Silberman was negotiating with Publicis and other shareholders to buy their stakes. Silberman and Medigus had previously acquired the cash shell Intellisense for the purpose of listing their subsidiary ScoutCam. The company suppressed publication of the official disclosure of Silberman's stake building for eight days, and did not publicly respond to Silberman, instead proposing that shareholders award bonuses to the current and former management team. These were subsequently approved by shareholders. On 13 February 2020, the Israeli medical device maker Medigus announced that they were in negotiations to buy 24.99% of the company from other shareholders. Four days later, Viola announced that they had sold their stake, and that the chairman of Matomy, who was also a partner at Viola, would be resigning from Matomy. The following day, Medigus announced that they